APA

Al-Rasheed N. M., Al-Oteibi M. M., Al-Manee R. Z., Al-Shareef S. A., Al-Rasheed N. M., Hasan I. H., Mohamad R. A. & Mahmoud A. M. (20160329). Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway. : Drug design, development and therapy.

Chicago

Al-Rasheed Nouf M, Al-Oteibi Maha M, Al-Manee Reem Z, Al-Shareef Sarah A, Al-Rasheed Nawal M, Hasan Iman H, Mohamad Raeesa A and Mahmoud Ayman M. 20160329. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway. : Drug design, development and therapy.

Harvard

Al-Rasheed N. M., Al-Oteibi M. M., Al-Manee R. Z., Al-Shareef S. A., Al-Rasheed N. M., Hasan I. H., Mohamad R. A. and Mahmoud A. M. (20160329). Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway. : Drug design, development and therapy.

MLA

Al-Rasheed Nouf M, Al-Oteibi Maha M, Al-Manee Reem Z, Al-Shareef Sarah A, Al-Rasheed Nawal M, Hasan Iman H, Mohamad Raeesa A and Mahmoud Ayman M. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway. : Drug design, development and therapy. 20160329.